轉染試劑與設備市場報告：2031 年趨勢、預測與競爭分析

由於學術和研究機構以及製藥和生物技術公司市場存在機會，全球轉染試劑和設備市場的未來前景光明。預計到 2031 年，全球轉染試劑和設備市場規模將達到 21 億美元，2025 年至 2031 年的複合年成長率為 6.5%。該市場的主要驅動力是全球慢性病負擔的增加、對合成基因的高需求以及轉染技術的進步。

• 根據 Lucintel 的預測，隨著主要企業推出多種產品來擴大其試劑組合，試劑有望在預測期內實現高成長。
• 根據最終用途，由於全球疾病負擔的增加以及試劑和設備的採用率的提高，製藥和生物技術公司可能繼續成為最大的細分市場。
• 從地區來看，預計北美將在預測期內繼續成為最大的地區，這得益於基因組學研發投資的增加、蛋白質療法的需求的不斷成長以及該地區主要參與者的存在。

轉染試劑和設備市場的策略性成長機會

轉染試劑和設備市場有幾個策略性成長機會：

• 基因治療：轉染技術在基因治療中的應用日益廣泛，這提供了巨大的成長機會，因為它增強了治療基因的傳遞並改善了治療結果。
• 藥物發現：快速研究基因功能和藥物交互作用將加速開發新藥。
• 癌症研究：增強的基因傳遞方法對於癌症研究至關重要，可以改善與癌症相關的基因和治療標靶的研究。
• 再生醫學：轉染技術對於再生醫學新治療方法的開發至關重要，並有助於組織工程和幹細胞研究的進步。
• 農業生物技術：轉染技術在農業生物技術中的潛力巨大，有助於開發基因改造作物，提高食品安全和農業生產力。

這些成長機會正在推動轉染技術應用在各個領域的擴展，從而推動市場成長和創新。

轉染試劑和設備市場促進因素與挑戰

影響轉染試劑和設備市場的因素很多，包括技術、經濟和監管。以下是關鍵促進因素和挑戰的分析：

推動轉染試劑和設備市場發展的因素包括：

• 技術進步：奈米粒子和自動化等技術創新改善了基因傳遞，透過提高效率和效力來推動市場成長。
• 增加研究投入：增加對生物技術和基因組學研究的投資將推動對先進轉染技術的需求，從而擴大市場。
• 基因治療需求不斷成長：基因治療應用的不斷擴大推動了對有效轉染技術的需求，從而推動了市場成長。
• 個人化醫療：個人化醫療的興起要求轉染技術能夠針對每位患者進行量身定做，進一步增加了對客製化解決方案的需求。

轉染試劑和設備市場的挑戰是：

• 高成本：先進的轉染試劑和設備的成本可能成為使用的障礙，特別是對於發展中地區的小型研究機構。
• 技術複雜性：新轉染技術的複雜性可能為使用者培訓和融入現有工作流程帶來挑戰。

這些市場促進因素和挑戰正在塑造轉染試劑和設備市場，並影響產業的成長模式和策略決策。

目錄

第1章執行摘要

第2章全球轉染試劑與設備市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球轉染試劑及設備市場趨勢（2019-2024）及預測（2025-2031）
• 全球轉染試劑和設備市場（按產品）
  • 試劑
  • 裝置
• 全球轉染試劑和設備市場（依方法）
  • 物理方法
  • 生化方法
  • 病毒方法
• 全球轉染試劑和設備市場（按應用）
  • 蛋白質生產
  • 生物醫學研究
  • 治療實施
• 全球轉染試劑和設備市場（依最終用途）
  • 學術和研究機構
  • 製藥和生物技術公司
  • 其他

第4章區域市場趨勢與預測分析（2019-2031）

• 全球轉染試劑和設備市場（按地區）
• 北美轉染試劑與設備市場
• 歐洲轉染試劑與設備市場
• 亞太轉染試劑與設備市場
• 世界其他地區的轉染試劑和設備市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球轉染試劑和設備市場成長機會（按產品）
  • 全球轉染試劑和設備市場成長機會（按方法）
  • 全球轉染試劑和設備市場的成長機會（按應用）
  • 全球轉染試劑和設備市場成長機會（以最終用途）
  • 全球轉染試劑和設備市場各區域成長機會
• 全球轉染試劑和設備市場的新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球轉染試劑和設備市場的產能
  • 全球轉染試劑和設備市場的企業合併
  • 認證和許可

第7章主要企業簡介

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen NV
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and pharmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $2.1 billion by 2031 with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

• Lucintel forecasts that, within the product category, the reagent is expected to witness higher growth over the forecast period due to a huge number of launches by key players to broaden their reagents portfolio.
• Within the end use category, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.
• In terms of regions, North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is evolving with several notable trends:

• Nanoparticle-Based Reagents: These reagents are becoming popular due to their effectiveness in gene delivery with minimal cytotoxicity. Their superior stability and targeting capabilities lead to higher success rates in transfection.
• Transfection Automation: Automation technologies facilitate high-throughput screening, reducing manual intervention. Automated systems enhance reproducibility and efficiency, supporting extensive research and therapeutic applications.
• Advanced Electroporation Systems: New developments in electroporation technology improve the precision and efficiency of gene delivery, enhancing the intracellular delivery of nucleic acids for gene therapy and genetic research.
• Integration with Gene Editing Tools: The merging of transfection technologies with tools like CRISPR/Cas9 is gaining traction, increasing the efficiency and specificity of genetic modifications.
• Applications in Personalized Medicine: Transfection technologies are increasingly tailored to individual genetic backgrounds, enhancing their effectiveness in gene therapies and targeted treatments.

These trends are driving innovation and expanding the applications of transfection reagents and equipment, thereby improving research and therapeutic development prospects.

Recent Developments in the Transfection Reagent and Equipment Market

Key developments in the transfection reagent and equipment market include:

• Nanoparticle Innovations: Advanced nanoparticle-based transfection reagents are enhancing gene delivery efficiency while reducing cytotoxicity, making them suitable for diverse research and therapeutic applications.
• High-Throughput Systems: The introduction of high-throughput transfection systems is streamlining workflows and increasing productivity in genomic research by enabling simultaneous processing of multiple samples.
• Cost-Effective Solutions: The design of novel, affordable reagents and equipment is making advanced transfection technologies more accessible, especially in developing regions, thus enhancing global research and development.
• Electroporation Technologies: New electroporation systems offer improved control over gene delivery accuracy and efficiency, expanding applications in gene therapy and cellular research.
• Integration with Advanced Technologies: The latest transfection technologies are increasingly integrated with advanced tools like CRISPR/Cas9, facilitating precise genetic alterations and innovative therapeutic approaches.

These developments are propelling the field towards more efficient, accessible, and precise applications.

Strategic Growth Opportunities for Transfection Reagent and Equipment Market

Several strategic growth opportunities exist within the transfection reagent and equipment market:

• Gene Therapy: The growing use of transfection technologies in gene therapy presents significant growth opportunities, enhancing the delivery of therapeutic genes and improving treatment outcomes.
• Drug Discovery: Transfection technologies are becoming essential in drug discovery processes, enabling rapid studies of gene function and drug interactions, thus accelerating new drug development.
• Cancer Research: Enhanced methodologies for gene delivery are crucial for cancer research, improving the study of cancer-related genes and therapeutic targets.
• Regenerative Medicine: Transfection technologies are vital in developing new treatments within regenerative medicine, contributing to advancements in tissue engineering and stem cell research.
• Agricultural Biotechnology: There is significant potential for transfection technologies in agricultural biotechnology, aiding in the development of genetically modified crops for enhanced food safety and agricultural productivity.

These growth opportunities are expanding the application of transfection technologies across various sectors, driving market growth and innovation.

Transfection Reagent and Equipment Market Driver and Challenges

The various factors affecting the transfection reagent and equipment market include technological, economic, and regulatory. Below is an analysis of major drivers and challenges:

The factors responsible for driving the transfection reagent and equipment market include:

• Technological Advancements: Innovations like nanoparticles and automation improve gene delivery, driving market growth through enhanced efficiency and effectiveness.
• Increased Research Investments: Growing investments in biotechnology and genomic research are boosting demand for advanced transfection technologies, leading to market expansion.
• Rising Demand for Gene Therapies: The expanding applications of gene therapy create a heightened need for effective transfection technologies, catalyzing market growth.
• Personalized Medicine: The advancement of personalized medicine necessitates tailored transfection techniques, further driving demand for customized solutions.

Challenges in the transfection reagent and equipment market are:

• High Costs: The expense of sophisticated transfection reagents and equipment can deter use, particularly in smaller research facilities in developing regions.
• Complexity of Technologies: The sophistication of new transfection technologies can present challenges in user training and integration into existing workflows.

These drivers and challenges shape the transfection reagent and equipment market, influencing growth patterns and strategic decisions within the industry.

List of Transfection Reagent and Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transfection reagents and equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment market by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Analysis by Value from 2019 to 2031]:

• Reagents
• Equipment

Transfection Reagent and Equipment Market by Method [Analysis by Value from 2019 to 2031]:

• Physical Methods
• Biochemical Methods
• Viral Methods

Transfection Reagent and Equipment Market by Application [Analysis by Value from 2019 to 2031]:

• Protein Production
• Biomedical Research
• Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Academics & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Transfection Reagent and Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is rapidly evolving, driven by continuous technological advancements and expanding applications in research and therapeutics. Recent developments in key markets include:

• United States: The U.S. market is experiencing significant growth due to advancements in nanoparticle-based transfection reagents and electroporation equipment, improving gene delivery efficiency for research and therapeutic applications.
• China: Increased domestic production of affordable reagents and equipment is fostering growth in China, enhancing accessibility for local researchers and biotech firms.
• Germany: Ongoing development of high-throughput transfection systems and reagents in Germany is improving workflow efficiency in genomic research and pharmaceutical development.
• India: Investment in biotechnology research and development is driving growth in transfection technologies, with initiatives focused on creating affordable and scalable solutions.
• Japan: Japan is prioritizing the integration of microfluidics and gene editing tools in transfection systems, enhancing precision and efficiency in gene delivery for various applications.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Transfection Reagent and Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Transfection Reagent and Equipment Market by Product
  • 3.3.1: Reagents
  • 3.3.2: Equipment
• 3.4: Global Transfection Reagent and Equipment Market by Method
  • 3.4.1: Physical Methods
  • 3.4.2: Biochemical Methods
  • 3.4.3: Viral Methods
• 3.5: Global Transfection Reagent and Equipment Market by Application
  • 3.5.1: Protein Production
  • 3.5.2: Biomedical Research
  • 3.5.3: Therapeutic Delivery
• 3.6: Global Transfection Reagent and Equipment Market by End Use
  • 3.6.1: Academics & Research Institutes
  • 3.6.2: Pharmaceutical & Biotechnology Companies
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Transfection Reagent and Equipment Market by Region
• 4.2: North American Transfection Reagent and Equipment Market
  • 4.2.1: North American Market by Product: Reagents and Equipment
  • 4.2.2: North American Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.3: European Transfection Reagent and Equipment Market
  • 4.3.1: European Market by Product: Reagents and Equipment
  • 4.3.2: European Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.4: APAC Transfection Reagent and Equipment Market
  • 4.4.1: APAC Market by Product: Reagents and Equipment
  • 4.4.2: APAC Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.5: ROW Transfection Reagent and Equipment Market
  • 4.5.1: ROW Market by Product: Reagents and Equipment
  • 4.5.2: ROW Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
  • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
  • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
  • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
  • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
• 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PromoCell
• 7.2: OriGene Technologies
• 7.3: Thermos Fisher Scientific
• 7.4: Merck
• 7.5: Bio-Rad Laboratories
• 7.6: Lonza
• 7.7: Qiagen N.V.
• 7.8: Mirus Bio
• 7.9: Promega Corporation
• 7.10: F. Hoffmann-La Roche